SCHEMBL29643339

SCHEMBL29643339

NC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAF1 P04049 9/20 0.82
▸ BRAF P15056 8/20 0.81
▸ KDR P35968 7/20 0.81
▸ RET P07949 3/20 0.81
▸ RIPK2 O43353 2/20 0.81
▸ ABCB11 O95342 2/20 0.81
▸ ABL1 P00519 2/20 0.81
▸ HTR1A P08908 2/20 0.81
▸ PDGFRB P09619 2/20 0.81
▸ ADORA3 P0DMS8 2/20 0.81
▸ KIT P10721 2/20 0.81
▸ FGFR1 P11362 2/20 0.81
▸ PDGFRA P16234 2/20 0.81
▸ FLT1 P17948 2/20 0.81
▸ MAOA P21397 2/20 0.81
▸ EPHA1 P21709 2/20 0.81
▸ TBXA2R P21731 2/20 0.81
▸ EPHA2 P29317 2/20 0.81
▸ TTK P33981 2/20 0.81
▸ EPHX2 P34913 2/20 0.81

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL432444 1.00 RAF1 (0.82) RAF1BRAFKDRRETRIPK2
SCHEMBL4609009 0.92 BRAF (0.82) RAF1BRAFKDRRETRIPK2
SCHEMBL4238109 0.91 RAF1 (0.82) RAF1BRAFKDRRETRIPK2
SCHEMBL29918250 0.91 RAF1 (1.00) RAF1BRAFKDRRETRIPK2
SCHEMBL548133 0.91 RAF1 (1.00) RAF1BRAFKDRRETRIPK2
SCHEMBL12333608 0.90 RAF1 (0.82) RAF1BRAFKDRRETRIPK2
SCHEMBL22627130 0.90 RAF1 (0.85) RAF1BRAFKDRRETRIPK2
Regorafenib SCHEMBL29351376 0.89 RAF1 (1.00) RAF1BRAFKDRRETRIPK2
Regorafenib SCHEMBL29349808 0.89 RAF1 (1.00) RAF1BRAFKDRRETRIPK2
Regorafenib SCHEMBL432230 0.89 RAF1 (1.00) RAF1BRAFKDRRETRIPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117899212-A Combination of regorafenib and a PD-1/PD-L1 (2) inhibitor for the treatment of cancer 拜耳医药保健有限责任公司 2024-04-19 — — CN disclosed
CN-110662540-B Combination of regorafenib and a PD-1/PD-L1 (2) inhibitor for the treatment of cancer 拜耳医药保健有限责任公司 2024-01-26 — — CN disclosed
CN-116392484-A Coated pharmaceutical composition containing regorafenib 拜尔健康护理有限责任公司 2023-07-07 — — CN disclosed
CN-116392485-A Coated pharmaceutical composition containing regorafenib 拜尔健康护理有限责任公司 2023-07-07 — — CN disclosed
CN-116392598-A Coated pharmaceutical composition containing regorafenib 拜尔健康护理有限责任公司 2023-07-07 — — CN disclosed
WO-2022148005-A1 MEDICINAL SOLID DISPERSION AND PREPARATION METHOD THEREFOR 湖南南新制药股份有限公司 2022-07-14 — — WO disclosed
WO-2022057164-A1 PREPARATION METHOD FOR MULTI-TARGET ANTI-TUMOR DRUG 广州南鑫药业有限公司 2022-03-24 — — WO disclosed
Send feedback